Markets.com Logo

ACXP

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    4.5211$
  • Previous Close
    4.7016$
  • 52 Week Change
    42.80$
  • Day Range
    -0.18$
  • 52 Week High/Low
    3.8$ - 46.6$
  • Dividend Per Share
    --
  • Market cap
    7 211 K$
  • EPS
    -1.89
  • Beta
    -1.263
  • Volume
    --

About

ACXP.US represents the common stock of Acurx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing new antibiotics for difficult-to-treat infections. Their primary focus is on developing oral antibiotics for hospital-acquired infections like Clostridium difficile infection (CDI). Investors purchase this stock hoping that the company's drug candidates will successfully navigate clinical trials, gain regulatory approval, and achieve commercial success, leading to a higher stock price.
Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Ghko B|--
Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Ghko B|--
ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

Ghko B|--
Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Ghko B|--

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

US Midterm Elections: Energy Sector Outlook and Investment Implications

Ava Grace|--
Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Ghko B|--

Factors

Please provide at least 3 factors. Clinical Trial Results: Positive trial outcomes for ACXP's drug candidates typically boost investor confidence, increasing demand and driving the stock price higher. Conversely, negative or inconclusive results can lead to a sell-off and a lower stock price.

Regulatory Approvals: Successful navigation of the regulatory process, such as FDA approval for a drug, is a major catalyst for stock price appreciation. Delays or rejections in regulatory reviews can negatively impact the stock.

Market Sentiment and Sector Trends: Overall market conditions and investor sentiment towards the pharmaceutical or biotechnology sector can influence ACXP.US's stock price. Positive sentiment and a bullish market often lift stock prices, while negative sentiment and a bearish market can drag them down.

People Also Watch

Latest news

Commodity Market Today: UAE to Leave OPEC After Nearly 60 Years in Major Blow to Oil Cartel

Commodity Market Today: UAE to Leave OPEC After Nearly 60 Years in Major Blow to Oil Cartel

Ghko B|--
Gold Price Today, April 30: XAUUSD Hits $4,575 Amid Escalating Global Economic Uncertainty

Gold Price Today, April 30: XAUUSD Hits $4,575 Amid Escalating Global Economic Uncertainty

Ghko B|--
Apple (AAPL) Q2 FY26 is coming: What’s going on with the Apple Supply Chain Stocks?

Apple (AAPL) Q2 FY26 is coming: What’s going on with the Apple Supply Chain Stocks?

Ghko B|--

Latest Education Articles

What Is Mirror Trading and How Does It Work?

What Is Mirror Trading and How Does It Work?

Julian Parker|--
What Is Short Selling? How Shorting Works in CFD Trading

What Is Short Selling? How Shorting Works in CFD Trading

Julian Parker|--
Leverage vs Margin Trading: Key Differences, Examples and Risks

Leverage vs Margin Trading: Key Differences, Examples and Risks

Julian Parker|--
Recommended Topics